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ofthe women diagnosed with ovarian can-
cer will die prematurely as a result. Little
is known of the causes of ovarian cancer;
epidemiologic studies suggest that men-
strual, environmental, and genetic factors
are important. Evidence for the role of
environmental factors is primarily popula-
tion based and suggest that dietary factors
and chemical carcinogens are contributors
to increased risk. The intramural and
extramural NIEHS expertise in the areas of
chemical carcinogenesis and growth factor
biology, along with ongoing research pro-
jects in the area ofgenetic predisposition to
ovarian cancer, provide the foundation for
an expanded and productive research agen-
da in this area.
Endometrial carcinoma is the most fre-
quently diagnosed gynecologic malignancy
in the United States, but remains the least
studied of the major cancers affecting
women. Unlike cancers of the breast and
ovary, endometrial cancer is limited pri-
marily to women over the age of 50, and
well-established risk factors suggest proba-
ble etiologic factors, most relating to estro-
gen. Researchers at NIEHS have used
molecular genetic approaches to distin-
guish etiologic factors and animal models
(including transgenic mice) to understand
the role of physiologic and environmental
factors in endometrial carcinogenesis.
Diethylstilbestrol as aModel for
Environmental Estrogens
The health effects of diethylstilbestrol
(DES) exposure are a research priority that
reflects the convergence of several related
investigative projects that are major areas
of concern for NIEHS. The synthetic
estrogen DES was administered to preg-
nant women during the 1940s through
1960s, originally for high-risk pregnancies
but later to promote "healthier babies" as
well. Subsequently, the drug was linked to
the development ofan otherwise extremely
rare malignancy, clear-cell carcinoma of
the vagina, in young female offspring
exposed in utero. In addition, a number of
more common non-neoplastic changes in
the reproductive tract of DES-exposed
daughters were identified, including vagi-
nal adenosis, cervical ectropion, and
numerous other structural abnormalities.
Although the public health hazards associ-
ated with further exposure to DES have
been largely eliminated, there are a number
of compelling reasons for the continued
study of DES-exposed women, as well as
for basic research on the biological effects
of DES and other environmental estro-
genic compounds.
First, it is unclear whether the human
cancer incidence resulting from DES expo-
sure has peaked. Although the majority of
DES daughters have passed the age range
for vaginal carcinoma development, few
have reached the age range (postmeno-
pausal) in which endometrial carcinoma
typically occurs in the DES unexposed
population, and endometrial carcinoma
occurs with a much higher prevalence than
vaginal carcinoma in DES-treated mice.
Similarly, the threat ofbreast cancer is still
a concern in this population. The identifi-
cation of molecular genetic markers for
DES carcinogenicity is therefore a continu-
ing priority; such markers would also be of
value in predicting risk for third-genera-
tion DES offspring, for whom little is
known about potential health risks.
Second, DES may be viewed as a
model compound for other environmental
agents with estrogenic potential. The
bioaccumulation of these environmental
estrogens is recognized as a problem of
increasing magnitude, and certain human
populations in the United States have been
shown to carry amounts of these fat-solu-
ble compounds which, in fish and other
wildlife, cause significant endocrine dys-
function and developmental anomalies of
the reproductive tract. Insights into the
biological effects of DES should therefore
provide a foundation upon which future
environmental health problems may be
effectively addressed.
NIEHS has a long history of accom-
plishments in conducting and supporting
research on estrogen action, hormonal car-
cinogenesis, and other types of estrogen-
related pathology, particularly for DES and
similar compounds. More recent achieve-
ments have provided insights into basic
mechanisms of estrogen receptor action at
the molecular level. A transgenic mouse
that overexpresses the estrogen receptor is
being developed to study tissue susceptibil-
ity and mechanisms for hormonal carcino-
genesis. New endeavors include the analy-
sis of human and animal tumors resulting
from DES exposure in utero for molecular
genetic alterations. Rapid advances in the
fields of molecular and developmental
biology have provided numerous insights
into relevant genes and molecular path-
ways involved in reproductive tract devel-
opment. Epidemiologic studies are fo-
cused on a broad range of health effects
among DES-exposed men and women.
Expanded research efforts are necessary to
use this knowledge in exploring the epige-
netic effects of DES in relation to repro-
ductive tract malformations at the molecu-
lar level.
In addition to the estrogen receptor,
research on the role of "orphan receptors"
in environmental disease is promising.
Identification and characterization of
orphan receptors and their endogenous lg-
ands will provide a link to understanding
the molecular mechanisms through which
exogenous chemicals may exert toxic
effects and through which natural sub-
stances influence physiologic processes.
For example, a recently discovered member
of the nuclear receptor family apparently
recognizes a class of foreign chemicals
called peroxisome proliferators, which
includes industrial plasticizers, herbicides,
and hypolipidemic agents. Similarly, a
receptor from another gene family exists
for the ubiquitous xenobiotic dioxin, or
TCDD. A related example is the retinoids,
which regulate differentiation and growth
of a variety of epithelial tissues including
mammary gland, cervical, vaginal, and
uterine epithelium. Ongoing research at
NIEHS is directed toward understanding
the process of squamous differentiation in
gynecologic epithelial tissues by retinoids
and estrogens, and interactions between
the retinoic acid receptor and estrogen
receptor signaling pathways. Further
research is necessary to define these path-
ways at the molecular level and to elucidate
possible therapeutic applications of retin-
oids in breast and other cancers.
Role ofthe Environment in
Osteoporosis
Osteoporosis is a complex disorder of the
skeletal system characterized by decreased
bone mass, which leads to increased skele-
tal fragility and fracturing. The pathogen-
esis ofthis metabolic disorder is likely to be
multifactorial, involving genetic, racial,
and environmental factors including smok-
ing, diet, and alcohol. Interactions be-
tween the endocrine and immune systems
appear to play a key role in maintaining
the physiological homeostasis in bone
metabolism. Exposure to estrogenic sub-
stances, a number ofwhich are widespread
in the environment, can influence bone
pathology, as can exposure to heavy metals.
Researchers at NIEHS are using cell cul-
ture and animal studies to investigate the
molecular mechanisms of estrogen recep-
tor-mediated effects on bone development
and metabolism, and NIEHS-supported
studies are investigating the role of metals
such as aluminum and cadmium in osteo-
dystrophies. Important questions remain
regarding the competition of these metals
with calcium in bone deposition and reab-
sorption. Because the condition appears to
be more severe in women without ovarian
activity (e.g., postmenopausal), under-
standing the modulatory effects of estro-
gens on heavy-metal toxicity may con-
tribute to our knowledge ofthe process of
osteoporosis.
We now know, that early exposure to
DES at very low doses can affect bone den-
sity. Basic and clinical studies are now
focusing on the potential role that dose
and time of exposure to estrogenic sub-
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stances may have on changes in bone den-
sity. These findings could play a signifi-
cant role in the development ofearly inter-
vention strategies for women with osteo-
porosis. In addition, clinical trials are
beginning at NIEHS to determine if
pathologic conditions that modify endoge-
nous estrogen levels and disrupt a normal
pubertal period (such as precocious puber-
ty or Turner syndrome) might also influ-
ence bone density at later stages of life.
The health and monetary costs of osteo-
porosis to our society are already enor-
mous, estimated at $7-10 billion annually
and affecting approximately 24 million
Americans, the majority of whom are
women. An estimated 50% of women
over age 45 and 90% of women over age
75 have osteoporosis. As the average age of
our society increases, the number ofpeople
afflicted with this disease will rise, resulting
in increased health care costs. Expanded
research in this area will extend our under-
standing from basic research studies to
clinical investigations and affected human
populations.
NIEHS to Play Unique Role in
Women's Health Research Effort
Human disease is largely the product of
the interaction between two factors, genet-
ics and the environment, throughout the
life span. Any large-scale research agenda
pertaining to human health must therefore
consider the entire life span, and it is clear
that women's health is worse over the
course of a life time than men's. It is
equally apparent that the environmental
component of this interaction has been
somewhat neglected by the biomedical
research community. A major research ini-
tiative addressing the environment and
women's health is therefore imperative.
The proposed initiative thus focuses on
hormonal carcinogenesis and endocrine
toxicology, with special emphasis on the
genetic and epigenetic molecular mecha-
nisms that underlie these phenomena.
With NIEHS's background, knowl-
edge, and ongoing research programs in
wom-en's health and insofar as a wide
range ofenvironmental agents possess hor-
monal potential and a significant percent-
age of women's health problems appear
related to dysfunction in hormonal path-
ways, this approach is likely to succeed.
Inclusion of the NIEHS extramural
(grants) component in the above areas will
undoubtedly facilitate research progress.
The diverse strengths ofextramurally fund-
ed research programs allow for important
health problems with an environmental
component, such as cardiovascular disease,
to be ad-dressed. Such a dual effort of the
NIEHS intramural and extramural re-
search programs will allow a comprehen-
sive, multidisciplinary, and inclusive
approach to this problem.
Contributing to this report on women's
health were Jeff Boyd, Laboratory ofMolecular
Carcinogenesis; J. Carl Barrett, Environmental
Carcinogenesis Program; Terri Damstra,
Program Coordination; and John McLachlan,
Office ofthe Director.
Minority Health Research
Treatment of lead toxicity, environmental
justice, and environmental health sciences
centers are among the minority health
issues that will be addressed through an
agreement between the National Institutes
ofHealth's Office ofResearch on Minority
Health (ORMH), and NIEHS. A memo-
randum of agreement between the two
NIH organizations provides NIEHS with
$5 million a year through 1997 to address
minority health concerns related to envi-
ronmental health.
John Ruffin, director of ORMH, and
Kenneth Olden, director of NIEHS,
signed the agreement March 29 at NIEHS
in Research Triangle Park, North Caro-
lina. The ORMH was established in 1990
to strengthen the efforts of NIH to im-
prove the health status of minority Amer-
icans through biomedical research and to
increase the participation of minorities in
biomedical research.
Funds provided through the agreement
will be apportioned between research pro-
grams relating to minority health and plan-
ning and research on issues ofenvironmen-
tal justice. Environmental justice addresses
pollution and environmental health risks
and their distribution across socioeconom-
ic classes and racial groups. Four major
efforts under the agreement are:
* Blood levels in children. Three to four
million children in the United States
have elevated blood lead levels. There are
two possible interventions to reduce the
problem. One is to reduce exposure
including lead abatement in homes, but
this will require years to accomplish. A
more immediate approach is to treat chil-
dren with a drug (chelating agent) that
will remove lead from the body.
Succimer is a new drug that holds
promise but has not been adequately test-
ed clinically for this purpose; it is the first
newly approved drug of its type (chelat-
ing agent) since 1950. NIEHS will sup-
port a clinical trial to establish the effec-
tiveness ofsuccimer. It is orally adminis-
tered, appears to be relatively safe, and
does not cause as much loss of necessary
elements such as zinc and iron as other
chelators. Contracts to conduct the trials
will be awarded in the next several
months.
* Lead in pregnant women. Research will
be conducted to learn to what extent the
release oflead stored in bone is increased
during pregnancy. This is an important
question in understanding how the devel-
oping fetus may be exposed through lead
exposure ofthe mother before pregnancy.
The research will focus on women from
Eastern Europe who were heavily
exposed to lead who have and then
migrated to Australia. This population
provides a unique opportunity for this
kind ofstudy because ofthe recognizable
differences in the nature of the lead iso-
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Focus on minority health. John Ruffin (left), director of the Office of Research on Minority Health, and
Kenneth Olden, director of NIEHS, sign a five-year agreement.
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